NASDAQ: PDEXPro Dex Inc Stock
$47.82+2.77 (+6.15%)
Updated Jul 3, 2025
PDEX Price
$47.82
Fair Value Price
$5.94
Market Cap
$155.94M
52 Week Low
$17.02
52 Week High
$70.26
P/E
16.78x
P/B
4.42x
P/S
2.52x
PEG
N/A
Dividend Yield
N/A
Revenue
$64.12M
Earnings
$9.37M
Gross Margin
31.4%
Operating Margin
20.49%
Profit Margin
14.6%
Debt to Equity
0.82
Operating Cash Flow
-$489k
Beta
0.59
Next Earnings
Aug 28, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PDEX Overview
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PDEX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
B
PDEX
Ranked#6 of 45
Ranked#6 of 45
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $6.16 | A | |
| $10.32 | B | |
| $93.58 | B |
Be the first to know about important PDEX news, forecast changes, insider trades & much more!
PDEX News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PDEX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PDEX ($47.82) is overvalued by 704.97% relative to our estimate of its Fair Value price of $5.94 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PDEX ($47.82) is not significantly undervalued (704.97%) relative to our estimate of its Fair Value price of $5.94 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PDEX is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PDEX due diligence checks available for Premium users.
Valuation
PDEX fair value
Fair Value of PDEX stock based on Discounted Cash Flow (DCF)
Price
$47.82
Fair Value
$5.94
Overvalued by
704.97%
PDEX ($47.82) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PDEX ($47.82) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PDEX is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PDEX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
16.78x
Industry
41.46x
Market
30.96x
PDEX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PDEX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PDEX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.42x
Industry
3.74x
PDEX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PDEX's financial health
Profit margin
Revenue
$17.4M
Net Income
$3.3M
Profit Margin
18.8%
PDEX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PDEX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$64.3M
Liabilities
$29.0M
Debt to equity
0.82
PDEX's short-term assets ($49.94M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PDEX's short-term assets ($49.94M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PDEX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PDEX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$754.0k
Investing
$1.7M
Financing
$1.9M
PDEX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PDEX vs Medical Stocks
Pro Dex Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.